Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity

A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES

Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189

Positional cloning of the mouse obese gene and its human homologue

Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419

Real time quantitative PCR.Preprint

Heid, C., Stevens, J., Livak, K. J., & Williams, P. (1996) · Genome Research · doi:10.1101/gr.6.10.986 · Cited by 6,180

Weight-Reducing Effects of the Plasma Protein Encoded by the obese Gene

Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., & Friedman, J. M. (1995) · Science · doi:10.1126/science.7624777 · Cited by 4,451

Effects of the obese Gene Product on Body Weight Regulation in ob / ob Mice

Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017

Obesity and insulin resistance

Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,345

The Spread of the Obesity Epidemic in the United States, 1991-1998

Mokdad, A. H. (1999) · JAMA · doi:10.1001/jama.282.16.1519 · Cited by 2,384

Cellular energy utilization and molecular origin of standard metabolic rate in mammals

Rolfe, D. F., & Brown, G. C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.3.731 · Cited by 2,021

Annual Deaths Attributable to Obesity in the United States

Allison, D. B. (1999) · JAMA · doi:10.1001/jama.282.16.1530 · Cited by 1,863

Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action

Frederich, R. C., Hamann, A., Anderson, S., Löllmann, B., Lowell, B. B., & Flier, J. S. (1995) · Nature Medicine · doi:10.1038/nm1295-1311 · Cited by 1,660

Regulation of Fgf15 expression in the intestine by glucocorticoid receptor

Jia, K., Zhang, D., Jia, Q., & Zhang, Q. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.9915 · Cited by 13

The Physiological Importance of Bile Acid Structure and Composition on Glucose Homeostasis

Higuchi, S. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01329-5 · Cited by 12

Oncogenic FGFR Fusions Produce Centrosome and Cilia Defects by Ectopic Signaling

Niţă, A., Abraham, S. P., Krejčı́, P., & Bosakova, M. K. (2021) · Cells · doi:10.3390/cells10061445 · Cited by 14

Association of FGF19, FGF21 and FGF23 with carbohydrate metabolism parameters and insulin resistance in patients with chronic kidney disease

Marchelek‐Myśliwiec, M., Dziedziejko, V., Dołęgowska, K., Pawlik, A., Safranow, K., Stępniewska, J., Wiśniewska, M., Małyszko, J., & Ciechanowski, K. (2020) · Journal of Applied Biomedicine · doi:10.32725/jab.2020.005 · Cited by 12

The New Markers of Early Obesity-Related Organ and Metabolic Abnormalities

Ziomber-Lisiak, A., Piana, K., Ostachowicz, B., Wróbel, P., Kasprzyk, P., Kaszuba-Zwoińska, J., Baranowska-Chowaniec, A., Juszczak, K., & Szczerbowska‐Boruchowska, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113437 · Cited by 13

Newly Identified Mechanisms of Total Parenteral Nutrition Related Liver Injury

Jain, A. K., & Teckman, J. H. (2014) · Advances in Hepatology · doi:10.1155/2014/621380 · Cited by 12

Farnesoid X receptor-dependent and -independent pathways mediate the transcriptional control of human fibroblast growth factor 19 by vitamin A

Jahn, D., Sutor, D., Dorbath, D., Weiß, J., Götze, O., Schmitt, J., Hermanns, H. M., & Geier, A. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.12.007 · Cited by 12

Developmental regulation of the intestinal FGF19 system in domestic pigs

Gavaldà‐Navarro, A., Pastor, J. J., Mereu, A., Villarroya, F., & Ipharraguerre, I. R. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00312.2017 · Cited by 12

Endocrine fibroblast growth factors as potential biomarkers for chronic kidney disease

Kondo, Y., Komaba, H., & Fukagawa, M. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1780918 · Cited by 12

Divergence in aerobic capacity impacts bile acid metabolism in young women

Maurer, A., Ward, J. L., Dean, K. M., Billinger, S. A., Lin, H., Mercer, K. E., Adams, S. H., & Thyfault, J. P. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00577.2020 · Cited by 12

Impact of Fibroblast Growth Factors 19 and 21 in Bariatric Metabolism

Patton, A., Khan, F. H., & Kohli, R. (2017) · Digestive Diseases · doi:10.1159/000450910 · Cited by 13

The link between gut microbiota and multiple sclerosis from the perspective of barrier function

Ren, J., Niu, Z., Wang, J., Guo, J., Hao, H.-J., Gao, F., Liu, R., & Wang, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1652796 · Cited by 13

Glycodeoxycholic Acid Inhibits Primary Bile Acid Synthesis With Minor Effects on Glucose and Lipid Homeostasis in Humans

Meessen, E. C. E., Majait, S., Ay, Ü., Damink, S. W. M. O., Romijn, J. A., Holst, J. J., Hartmann, B., Kuipers, F., Nieuwdorp, M., Schaap, F. G., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae399 · Cited by 10

Aberrant FGFR4 signaling worsens nonalcoholic steatohepatitis in FGF21KO mice

Yu, Y., Shi, X., Zheng, Q., Wang, X., Liu, X., Tan, M., Lv, G., Zhang, P., Martin, R. C. G., & Li, Y. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.58776 · Cited by 11

Beyond lipids: Novel mechanisms for parenteral nutrition–associated liver disease

Wichman, B. E., Nilson, J., Govindan, S., Chen, A., Jain, A., Arun, V., Derdoy, J., Krebs, J., & Jain, A. K. (2022) · Nutrition in Clinical Practice · doi:10.1002/ncp.10830 · Cited by 11

Endocrine FGFs and their signaling in the brain: Relevance for energy homeostasis

Zangerolamo, L., Carvalho, M. U. W. B. D., Velloso, L. A., & Barbosa, H. C. L. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176248 · Cited by 11

Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose

Zhang, J., Li, H., Zhou, H., Fang, L., Xu, J., Yan, H., Chen, S., Song, Q., Zhang, Y., Xu, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06252-6 · Cited by 11

Molecular regulators of lipid metabolism in the intestine – Underestimated therapeutic targets for obesity?

Dávalos-Salas, M., Mariadason, J. M., Watt, M. J., & Montgomery, M. K. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114091 · Cited by 11

TCF7L2 transcriptionally regulates Fgf15 to maintain bile acid and lipid homeostasis through gut‐liver crosstalk

Bhat, N., Esteghamat, F., Chaube, B., Gunawardhana, K., Mani, M., Thames, C., Jain, D., Ginsberg, H. N., Fernandes‐Hernando, C., & Mani, A. (2022) · The FASEB Journal · doi:10.1096/fj.202101607r · Cited by 11

Bromodomain Inhibition Reveals FGF15/19 As a Target of Epigenetic Regulation and Metabolic Control

Kozuka, C., Efthymiou, V., Sales, V., Zhou, L., Osataphan, S. A., Yuchi, Y., CHIMENE-WEISS, J. I., Mulla, C. M., ISGANAITIS, E. M., Desmond, J., et al. (2022) · Diabetes · doi:10.2337/db21-0574 · Cited by 11

Enterohepatic bacterial infections dysregulate the FGF15-FGFR4 endocrine axis

Romain, G., Tremblay, S., Arena, E. T., Antunes, L. C. M., Covey, S. D., Chow, M., Finlay, B. B., & Menéndez, A. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-238 · Cited by 11

Role of fibroblast growth factor 19 in maintaining nutrient homeostasis and disease.

Zhang, J., Li, H. T., Fang, Q. C., & Jia, W. (2014) · PubMed · doi:10.3967/bes2014.056 · Cited by 11

New advances in drug development for metabolic dysfunction-associated diseases and alcohol-associated liver disease

Zhang, J., Li, Y., Liu, Y., Ma, N., Qian, S., Chen, Y., Duan, Y., Xiang, X., & He, Y. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01267-9 · Cited by 10

Bile Acids in Control of the Gut-Liver-Axis

Hild, B., Heinzow, H. S., Schmidt, H., & Maschmeier, M. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1330-9644 · Cited by 10

Fibroblast Growth Factor 19 in Gestational Diabetes Mellitus and Fetal Growth

Yang, M., Huang, R., Liu, X., Xu, Y., Wang, W., He, H., Zhang, G., Zheng, T., Fang, F., Fan, J., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.805722 · Cited by 10

Prolonged Antibiotic Exposure during Adolescence Dysregulates Liver Metabolism and Promotes Adiposity in Mice

Carson, M. D., Warner, A. J., Geiser, V. L., Hathaway‐Schrader, J. D., Alekseyenko, A. V., Marshall, J. L., Westwater, C., & Novince, C. M. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.02.014 · Cited by 10

Gut microbiome metabolites as key actors in atherosclerosis co-depression disease

Liao, X.-X., Wu, X., Zhou, Y.-L., Li, J., Wen, Y.-L., & Zhou, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.988643 · Cited by 10

The Role of the FGF19 Family in the Pathogenesis of Gestational Diabetes: A Narrative Review

Sadowska, A., Poniedziałek‐Czajkowska, E., & Mierzyński, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417298 · Cited by 9

Research progress on the role of FGF21 in insulin resistance

Zhang, H., Zhu, R., Sun, Q., & Du, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1619462 · Cited by 10

Modulation of Fibroblast Growth Factor 19 Expression by Bile Acids, Meal Replacement and Energy Drinks, Milk, and Coffee

Styer, A. M., Roesch, S. L., & Argyropoulos, G. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085558 · Cited by 9

Fibroblast growth factor 19 secretion and function in perinatal development

Vonderohe, C. E., Guthrie, G. J., & Burrin, D. G. (2023) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00208.2022 · Cited by 9

Benefits of Combining Sonchus brachyotus DC. Extracts and Synbiotics in Alleviating Non-Alcoholic Fatty Liver Disease

Huang, W.-W., Shen, B., Li, X., Zhang, T., & Zhou, X. Q. (2023) · Foods · doi:10.3390/foods12183393 · Cited by 8

Central FGF19 signaling enhances energy homeostasis and adipose tissue thermogenesis through sympathetic activation in obese mice

Zangerolamo, L., Carvalho, M. U. W. B. D., Solon, C., Sidarta-Oliveira, D., Soares, G. M., Marmentini, C., Boschero, A. C., Tseng, Y., Velloso, L. A., & Barbosa, H. C. L. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00488.2024 · Cited by 9

Optimization of Peptide Inhibitors of β-Klotho as Antagonists of Fibroblast Growth Factors 19 and 21

Pan, J. B., Parlee, S. D., Brunel, F. M., Li, P., Lu, W., Pérez–Tilve, D., Liu, F., Finan, B., Kharitonenkov, A., & DiMarchi, R. D. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00100 · Cited by 9

Fibroblast Growth Factor 23 is Associated With Adiposity in Patients Receiving Hemodialysis: Possible Cross Talk Between Bone and Adipose Tissue

Chiang, J. M., Kaysen, G. A., Schafer, A. L., Delgado, C., & Johansen, K. L. (2018) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2017.12.010 · Cited by 8

A short report on NGM282/aldafermin for the treatment of nonalcoholic steatohepatitis (NASH)

Roberts, S. K., & Majeed, A. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1999416 · Cited by 8

∆nFGF1 Protects β ‐Cells against High Glucose‐Induced Apoptosis via the AMPK/SIRT1/PGC‐1 α Axis

Chen, Q., Chen, X., Jia, Z., Du, Y., Zhang, S., Xu, W., Pan, B., Lou, J., Zhou, J., Zhou, J., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1231970 · Cited by 8

Bile Acid Sequestrants

Guyton, J. R., & Goldberg, A. C. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50027-5 · Cited by 8

Pathology and Therapeutic Significance of Fibroblast Growth Factors

Edirisinghe, O., Ternier, G., & Kumar, T. K. S. (2025) · Targets · doi:10.3390/targets3010005 · Cited by 8

Personalized approaches to lung cancer treatment: A review of targeted therapies, pharmacogenomics, and combination strategies

Namini, M. T., Bhagya, G., & Sharma, M. (2025) · Aspects of Molecular Medicine · doi:10.1016/j.amolm.2025.100073 · Cited by 7

Pathogenetic therapeutic approaches for endocrine diseases based on antisense oligonucleotides and RNA-interference

Golounina, O. O., Minniakhmetov, I. R., Ринатович, С. Р., Khusainova, R. I., Zakharova, E., Bychkov, I. O., & Mokrysheva, N. G. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1525373 · Cited by 8

A new FGF15 /19‐mediated gut‐to‐heart axis controls cardiac hypertrophy

Morón‐Ros, S., Blasco‐Roset, A., Navarro‐Gascon, A., Rupérez, C., Zamora, M., Crispi, F., Uriarte, I., Fernández‐Barrena, M. G., Avila, M. A., Ferrer‐Curriu, G., et al. (2023) · The Journal of Pathology · doi:10.1002/path.6193 · Cited by 7

Polyguluronate sulfate and its oligosaccharides but not heparin promotes FGF19/FGFR1c signaling

Lan, Y., Zeng, X., Guo, Z., Zeng, P., Hao, C., Zhao, X., Yu, G., & Zhang, L. (2017) · Journal of Ocean University of China · doi:10.1007/s11802-017-3195-x · Cited by 7

The effect of aldafermin expressing-Escherichia coli Nissle 1917 along with dietary change on visceral adipose tissue in MASLD mouse model

Iannone, V., Vaittinen, M., Gómez-Gallego, C., Mikkonen, S. J., Lok, J., D’Auria, G., Vazquez-Uribe, R., Tikkanen, I., Sommer, M. O. A., El-Nezami, H. S., et al. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01774-w · Cited by 6

Fexaramine as the intestine-specific farnesoid X receptor agonist: A promising agent to treat obesity and metabolic disorders

Dąbrowska, A. M., & Dudka, J. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104386 · Cited by 6

FGF19 Promotes the Proliferation and Insulin Secretion from Human Pancreatic β Cells Via the IRS1/GLUT4 Pathway

Zeng, T., Tang, X., Bai, X., & Xiong, H. (2024) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2250-7830 · Cited by 6

A primer on the pleiotropic endocrine fibroblast growth factor FGF19/FGF15

Bouju, A., Nusse, R., & Wu, P. V. (2024) · Differentiation · doi:10.1016/j.diff.2024.100816 · Cited by 7

Soluble Expression of hFGF19 without Fusion Protein through Synonymous Codon Substitutions and DsbC Co-Expression in E. coli

Choi, H., Cheong, D., Yoo, S., Park, J., Lee, D.-H., & Kim, G. (2020) · Microorganisms · doi:10.3390/microorganisms8121942 · Cited by 6

Fibroblast growth factor 15, induced by elevated bile acids, mediates the improvement of hepatic glucose metabolism after sleeve gastrectomy

Wei, M., Cao, W.-B., Zhao, R.-D., Sun, D.-P., Liang, Y.-Z., Huang, Y., Cheng, Z.-W., Ouyang, J., Yang, W.-S., & Yu, W. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i21.3280 · Cited by 6

Vertical sleeve gastrectomy improves glucose-insulin homeostasis by enhancing β-cell function and survival via FGF15/19

Soares, G. M., Balbo, S. L., Bronczek, G. A., Vettorazzi, J. F., Marmentini, C., Zangerolamo, L., Velloso, L. A., & Carneiro, E. M. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00218.2023 · Cited by 5

Abnormalities of lipid metabolism, gallstone disease and gallbladder function

Zanlungo, S., Rigotti, A., Miquel, J. F., & Nervi, F. O. (2011) · Clinical Lipidology · doi:10.2217/clp.11.22 · Cited by 6

Preclinical pharmacokinetic characterization of an adipose tissue-targeting monoclonal antibody in obese and non-obese animals

Rajan, S., Mandikian, D., Baruch, A., Gelzleichter, T. R., Stevens, D. W., Sonoda, J., Cowan, K. J., Boswell, C. A., & Stefanich, E. G. (2017) · mAbs · doi:10.1080/19420862.2017.1373923 · Cited by 6

Thyroid Hormones Regulate Goblet Cell Differentiation and Fgf19-Fgfr4 Signaling

Blitz, E., Matsuda, H., Günther, S., Morikawa, T., Kubota, Y., Zada, D., Lerer‐Goldshtein, T., Stainier, D. Y. R., & Appelbaum, L. (2021) · Endocrinology · doi:10.1210/endocr/bqab047 · Cited by 6

Bile Acid Sequestrants as a Therapeutic Option for Glucose Lowering in Type 2 Diabetes Mellitus

Levy, P. (2008) · Endocrine Practice · doi:10.4158/ep.14.5.644 · Cited by 6

Sulfated Glycosaminoglycan-Assisted Receptor Specificity of Human Fibroblast Growth Factor (FGF) 19 Signaling in a Mouse System Is Different from That in a Human System

Nakamura, M., Uehara, Y., Asada, M., Suzuki, M., & Imamura, T. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112463820 · Cited by 6

Bariatric Surgery and the Mechanism of Diabetes Remission: Are We Getting There?

Haluzı́k, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3698 · Cited by 6

Deficiency of Epithelial PIEZO1 Alleviates Liver Steatosis Induced by High-Fat Diet in Mice

Xu, Z., Xu, S., Liu, X., Cheng, L., Liu, X., Xie, X., Zhou, D., Wang, D., Chen, J., Deng, X., et al. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.102906 · Cited by 5

Common channel length and implications to the weight loss

Santoro, S., Filippe Camarotto, M. O. T. A., de Aquino, C. G. G., & de Godoy, E. P. (2025) · Updates in Surgery · doi:10.1007/s13304-025-02343-6 · Cited by 6

Age of Cafeteria Diet Onset Influences Obesity Phenotype in Mice in a Sex-Specific Manner

Bazhan, N., Kazantseva, A., Dubinina, A., Balybina, N. Y., Jakovleva, T., & Makarova, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212436 · Cited by 4

High-fat diet promotes gestational diabetes mellitus through modulating gut microbiota and bile acid metabolism

Yao, L., Zhou, X., Jiang, X., Chen, H., Li, Y., Xiao, X., Tang, Y., Zhang, H., & Qiao, P. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1480446 · Cited by 7

The Role of Bile Acids in Gut-Hormone-Induced Weight Loss After Bariatric Surgery: Implications for Appetite Control and Diabetes

Roberts, R. E., Alaghband‐Zadeh, J., & le Roux, C. W. (2011) · Springer eBooks · doi:10.1007/978-0-387-92271-3_85 · Cited by 5

The role of fibroblast growth factor 19 in the pathogenesis of nonalcoholic fatty liver disease

Chrysavgis, L., Giannakodimos, I., Chatzigeorgiou, A., Τζιόμαλος, Κ., Papatheodoridis, G., & Cholongitas, Ε. (2022) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2022.2127408 · Cited by 5

FGF15 Protects Septic Mice by Inhibiting Inflammation and Modulating Treg Responses

Li, X., Zhu, Z., Xia, Z., & Xu, B. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s387613 · Cited by 5

Factors associated with fibroblast growth factor 19 increment after oral glucose loading in patients who were previously admitted for coronary angiography

Wang, J., Lee, C.-L., Lee, W., Lee, I., Lin, S., Lee, W.-L., Liang, K., & Sheu, W. H. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.09.006 · Cited by 5

Gut Microbiota Influence Lipid and Glucose Metabolism, Energy Homeostasis and Inflammation Through Effects on Bile Acid Metabolism

Tungland, B. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814649-1.00003-x · Cited by 5

Immunity and Gut Microbiome: Role of Probiotics and Prebiotics

Keerthi, T. R., Narayanan, R., Sreelekshmi, K., & Chandran, C. H. (2021) · Microorganisms for sustainability · doi:10.1007/978-981-16-0223-8_2 · Cited by 5

Bromocriptine sensitivity in bromocriptine-induced drug-resistant prolactinomas is restored by inhibiting FGF19/FGFR4/PRL

Zhu, Z., Hu, B., Zhu, D., Li, X., Chen, D., Wu, N., Rao, Q. X., Zhang, Z., Wang, H., & Zhu, Y. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02408-0 · Cited by 5

Fibroblast growth factor (FGF)-21 signals through both FGF receptor-1 and 2

Ren, G., Yin, J., Wang, W., Li, L., & Li, D. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-4035-z · Cited by 5

Secreted proteins in treating metabolic dysfunction-associated steatotic liver disease: from bench towards bedside

Huang, Y., Liu, B., Hu, C., & Lu, Y. (2025) · Protein & Cell · doi:10.1093/procel/pwaf027 · Cited by 4

Metabolic and behavioral parameters of mice with reduced expression of Syndecan-1

Gougoula, C., Bielfeld, A. P., Pour, S. J., Sager, M., Krüssel, J.-S., Benten, W. P. M., & Baston-Büst, D. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219604 · Cited by 4

Relationship Between Fibroblast Growth Factor 19 and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus

Chung, J. O., Park, S., Cho, D. H., Chung, D. J., & Chung, M. Y. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s339954 · Cited by 4

Fibroblast growth factor 19 stimulates water intake

Bedoya, J. U., Chavey, C., Desandré, G., Meunier, L., Dupuy, A., Dopeso‐Reyes, I. G., Tordjmann, T., Assénat, E., Hibner, U., & Grégoire, D. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101483 · Cited by 5

The effects of fasting diets on nonalcoholic fatty liver disease

Mokhtari, Z., Hosseini, E., Hekmatdoost, A., Haskey, N., Gibson, D. L., & Askari, G. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuac092 · Cited by 4

Fibroblast Growth Factor 19 Activates the Unfolded Protein Response and Mitogen-Activated Protein Kinase Phosphorylation in H-69 Cholangiocyte Cells

Qureshi, H. A. (2014) · Journal of Liver · doi:10.4172/2167-0889.1000158 · Cited by 4

Recent advances in brown adipose tissue biology

Shen, Y., Liu, X., Dong, M., Lin, J., Zhao, Q., Lee, H.-J., & Jin, W. (2014) · Chinese Science Bulletin · doi:10.1007/s11434-014-0386-3 · Cited by 4

Regulatory Factors that Reveal Three Distinct Adipocytes : The Brown, the White and the Brite

Waldén, T. B. (2010) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 4

Gut-muscle communication links FGF19 levels to the loss of lean muscle mass following rapid weight loss

Wean, J., Baranwal, S., Miller, N., Shin, J. H., O’Rourke, R. W., Burant, C., Seeley, R. J., Rothberg, A. E., & Bozadjieva-Kramer, N. (2024) · Diabetes & Metabolism · doi:10.1016/j.diabet.2024.101570 · Cited by 4

The role of FGF19–FGFR4 signaling pathway in liver health and disease: Guardian or destroyer

Wu, Z., Wang, Y., Zhang, J., Li, S., Wen, J., Hu, D., Jiang, J., Zhang, Z., Luo, X., & Xia, L. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101989 · Cited by 3

Expression of FGF19 gene as an effective gene for the invasive behavior of cancer cells in patients with colorectal cancer

Yavari, R., Bostanabad, S. Z., & Gharibi, A. (2019) · International Journal of Advanced Biological and Biomedical Research · doi:10.33945/sami/ijabbr.2019.2.6 · Cited by 3

Endocrinological Features of Hartsfield Syndrome in an Adult Patient With a Novel Mutation of FGFR1

Kobayashi, S., Tanigawa, J., Kondo, H., Nabatame, S., Maruoka, A., Sho, H., Tanikawa, K., Inui, R., Otsuki, M., Shimomura, I., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa041 · Cited by 3

High concentration of serum FGF19 at ICU admission is associated with 28-day mortality in sepsis patients

Li, X., Zhou, T., Zhu, Z., & Xu, B. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.11.002 · Cited by 3

Effects of apical sodium-bile acid transporter inhibitor and obeticholic acid co-treatment in experimental non-alcoholic steatohepatitis

Matye, D. J., Qin, X., Hasan, M. N., Gu, L., Clayton, Y. D., Li, F., & Li, T. (2022) · Liver Research · doi:10.1016/j.livres.2022.11.002 · Cited by 3

Ingestion of whey protein and β-conglycinin exerts opposite effects on intestinal FGF15 and serotonin secretion in mice

Nonogaki, K., & Kaji, T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1080790 · Cited by 3

Белок клото и сердечно-сосудистая система

Тюренков, И. Н., Perfilova, V. N., Нестерова, А. А., & Глинка, Е. Ю. (2021) · Biochemistry (Moscow) · doi:10.31857/s0320972521020020 · Cited by 3

Sarcopenia and sarcopenic obesity after cholecystectomy: A population‐based study

Gan, D., Wang, X., Xu, X., Kang, Q., Lu, Z., Jia, M., Ru, Y., He, X., Mou, Y., He, W., et al. (2021) · Obesity · doi:10.1002/oby.23334 · Cited by 4

STUDIES ON THE HORMONAL REGULATION OF BILE ACID SYNTHESIS

Lundåsen, T. (2007) · Figshare · Cited by 3

Fibroblast growth factor 15 overexpression and combined peroxisome proliferator–activated receptor α activation attenuates metabolic dysfunction–associated steatohepatitis progression in mice

Shi, H. Q., Stofan, M., Kong, B., Taylor, R. E., Henry, Z. R., Maliha, S., Rizzolo, D., & Guo, G. L. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100128 · Cited by 2

Analysis of prevalence and associated biomarkers of sarcopenia in older adults living in rural community in Wuhan, China

Yun, Z., Zhang, K., Zhang, Y., He, P., & Wang, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1635234 · Cited by 4

FGF19/FGFR4 axis drives immunosuppressive macrophage plasticity in hepatocellular carcinoma

Zhang, Y., Xiao, Y., Wang, C., Liu, X., He, J., Zhou, Y., Chen, Y., Zhao, H., & Li, Y. (2026) · Fundamental Research · doi:10.1016/j.fmre.2026.03.004 · Cited by 2

Relationship between the levels of serum fibroblast growth factor 19 and metabolic factors in obese and normal weight subjects with and without type 2 diabetes mellitus: a case-control study

Razmi, H., Tarighat‐Esfanjani, A., Payahoo, L., Mobasseri, M., Amirpour, M., Mirzaei, E., & Ghoreishi, Z. (2021) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2020-0075 · Cited by 2

Quantification of serum fibroblast growth factor-19 concentration in healthy dogs before and after feeding

Myers, J., Granger, L., Keeton, S., Liu, C., & Johnston, A. N. (2021) · American Journal of Veterinary Research · doi:10.2460/ajvr.82.8.676 · Cited by 3

Systematic pharmacological analysis of agonistic and antagonistic fibroblast growth factor receptor 1 MAbs reveals a similar unique mode of action

Chan, J., Chan, J., Shao, L., Stawicki, S., Pham, V. C., Akita, R., Hafner, M., Crocker, L. M., Yu, K., Koerber, J. T., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102729 · Cited by 2

Relationship between serum fibroblast growth factor 19 and vascular endothelial growth factor and soluble klotho protein in type 1 diabetic children

Zhang, Y., Li, G., Xiao, F., Wang, B., Li, J., Jia, X.-H., Sun, Y., & Chen, H. (2023) · BMC Pediatrics · doi:10.1186/s12887-023-03938-x · Cited by 2

Cross‐sectional and Mendelian randomization study of fibroblast growth factor 19 reveals causal associations with metabolic diseases

Li, Y., Dai, C., Yang, H., Zeng, H., Ruan, Y., Dai, M., Hao, J., Wang, L., Yan, X., & Ji, F. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16687 · Cited by 2

Long-term levels of bile acids, fibroblast growth factor-19, and glucagon-like peptide-1 after bariatric surgery

Kim, M. K., Kwon, H., Baek, K., & Song, K. (2024) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2024.10.004 · Cited by 2

The Molecular Bases for FGF Receptor Activation in Craniosynostosis and Dwarfism Syndromes

Beenken, A., & Mohammadi, M. (2011) · Monographs in human genetics · doi:10.1159/000318837 · Cited by 2

New EMBO Member's Review Endocrine functions of bile acids

Auwerx, J. H. (2006) · Cited by 2

What if Prometheus had steatosis? Potential use of FGF19 to promote regeneration of the fatty liver

Brown, P. M., & Rotman, Y. (2017) · Gut · doi:10.1136/gutjnl-2017-313712 · Cited by 2

Glucose and lipopolysaccharide differentially regulate fibroblast growth factor 21 in healthy male human volunteers – A prospective cross‐over trial

Pohlhammer, J., Heinzl, M. W., Klammer, C., Feldbauer, R., Rosenberger, K., Resl, M., Wagner, T., Obendorf, F., Egger-Salmhofer, M., Dieplinger, B., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17614 · Cited by 1

Fibroblast Growth Factor 21 as a Novel Metabolic Regulator

Micanovic, R., Dunbar, J. D., & Kharitonenkov, A. (2011) · Wiley eBooks · doi:10.1002/9780470910016.ch14 · Cited by 2

Printed in U.S.A. Copyright © 2002 by The Endocrine Society Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity

Tomlinson, E., Fu, L., John, L., Hultgren, B., Huang, X., Renz, M., Stephan, J. P., Tsai, S. P., Powell-Braxton, L., French, D. M., et al. (2013)

Fibroblast Growth Factor 19 Increases Metabolic Rate and Reverses Dietary and Leptin-Deficient Diabetes

Fu, L., John, L. M., Adams, S. H., Yu, X. X., Tomlinson, E., Renz, M. E., Williams, P. M., Soriano, R. H., Corpuz, R. T., Moffat, B., et al. (2004) · Endocrinology · doi:10.1210/en.2003-1671 · Cited by 584

Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/en.2003-1671 Fibroblast Growth Factor 19 Increases Metabolic Rate and Reverses Dietary and Leptin-Deficient Diabetes

Fu, L., John, L. M., Adams, S. H., Yu, X. X., Tomlinson, E., Renz, M. E., Williams, P. M., Soriano, R., Corpuz, R. T., Moffat, B., et al. (2013)

Cell-autonomous Action of the FGF19 Promotes UCP1 Expression and Function in Human Brown Adipocytes

Zangerolamo, L., Huang, T. L., Barbosa, H. C. L., & Tseng, Y. (2024) · Physiology · doi:10.1152/physiol.2024.39.s1.1769

The anti‐obesity effect of FGF19 occurs independent of the thermogenic protein UCP1

Samms, R. J., Antonellis, P. J., Bauer, S. M., Smith, D. P., O’Farrell, L. S., Culver, A. E., Hamang, M., Perfield, J. W., Coşkun, T., Yaden, B. C., et al. (2017) · The FASEB Journal · doi:10.1096/fasebj.31.1_supplement.886.12